Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Nov 9, 2011 · 10-Q · 40 days after period end · 0001140361-11-052700
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$1.47M | $218.89K |
| EPS Diluted | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 9, 2011 · 40 d after period end
